Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferric Maltol for Iron Deficiency in Heart Failure
NCT05697211Phase 4Completed
- Sponsor
- Hannover Medical School
- Start
- Feb 2023
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ferric maltol in iron deficiency anemia (IDA), sponsored by Hannover Medical School. Started Feb 2023; status: completed.
02
Drugs
ferric maltol
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT05697211.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05697211.